avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hnf1a | mm10_v2_chr5_-_114971056_114971079 | 0.47 | 3.5e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr15_+_10215955 Show fit | 15.57 |
ENSMUST00000130720.1
|
prolactin receptor |
|
chr11_+_101367542 Show fit | 13.92 |
ENSMUST00000019469.2
|
glucose-6-phosphatase, catalytic |
|
chr7_+_140763739 Show fit | 13.68 |
ENSMUST00000026552.7
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
chr1_-_130661584 Show fit | 13.38 |
ENSMUST00000137276.2
|
complement component 4 binding protein |
|
chr1_-_130661613 Show fit | 12.99 |
ENSMUST00000027657.7
|
complement component 4 binding protein |
|
chr5_+_90518932 Show fit | 12.66 |
ENSMUST00000113179.2
ENSMUST00000128740.1 |
afamin |
|
chr11_-_84167466 Show fit | 11.62 |
ENSMUST00000050771.7
|
predicted gene 11437 |
|
chr5_-_89457763 Show fit | 11.41 |
ENSMUST00000049209.8
|
group specific component |
|
chr5_-_87337165 Show fit | 10.70 |
ENSMUST00000031195.2
|
UDP glucuronosyltransferase 2 family, polypeptide A3 |
|
chr1_+_88211956 Show fit | 10.61 |
ENSMUST00000073049.6
|
UDP glucuronosyltransferase 1 family, polypeptide A1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 37.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.6 | 23.6 | GO:0052695 | cellular glucuronidation(GO:0052695) |
2.8 | 17.0 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
2.6 | 15.6 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 15.4 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
2.3 | 13.9 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.5 | 13.7 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 13.2 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.6 | 11.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
3.5 | 10.6 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 40.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 27.5 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 24.7 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 20.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
1.9 | 17.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) insulin-like growth factor ternary complex(GO:0042567) |
0.8 | 10.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 10.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 9.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
1.8 | 7.1 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.0 | 6.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 49.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.1 | 42.8 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.4 | 17.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) protein serine/threonine kinase activator activity(GO:0043539) |
3.1 | 15.6 | GO:0004925 | prolactin receptor activity(GO:0004925) |
4.6 | 13.9 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.4 | 13.7 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 13.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
4.2 | 12.7 | GO:0008431 | vitamin E binding(GO:0008431) |
3.8 | 11.4 | GO:1902271 | D3 vitamins binding(GO:1902271) |
2.5 | 10.1 | GO:0004058 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 22.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 22.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 15.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 13.9 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 9.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.4 | 7.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 7.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 7.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 4.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 3.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 18.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
1.2 | 16.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.8 | 15.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
4.6 | 13.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 11.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.5 | 10.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.6 | 9.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 7.9 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.6 | 7.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 7.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |